SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
1-Year Return
17.43%
This Quarter Return
+13.67%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$871M
AUM Growth
+$290M
(+50%)
Cap. Flow
+$211M
Cap. Flow
% of AUM
24.19%
Top 10 Holdings %
Top 10 Hldgs %
66.75%
Holding
73
New
20
Increased
22
Reduced
4
Closed
14
Top Buys
| 1 |
Iterum Therapeutics
ITRM
|
$18.8M |
| 2 |
AGN
Allergan plc
AGN
|
$17M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$16.3M |
| 4 |
Kiniksa Pharmaceuticals
KNSA
|
$16M |
| 5 |
CELG
Celgene Corp
CELG
|
$14.6M |
Top Sells
| 1 |
NCNA
NuCana
NCNA
|
$76.2M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$17.1M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$6.51M |
| 4 |
ATYR
aTyr Pharma
ATYR
|
$4.95M |
| 5 |
Bristol-Myers Squibb
BMY
|
$951K |
Sector Composition
| 1 | Healthcare | 82.28% |
